Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sheela, S.
Right arrow Articles by Barrett, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheela, S.
Right arrow Articles by Barrett, J. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 Oxford University Press

research-article

In vitro degradation of radiolabelled, intact basement membrane mediated by cellular plasminogen activator

S. Sheela and J. Carl Barrett 1

Environmental Carcinogenesis Group, Laboratory of Pulmonary Function and Toxicology, National Institute of Environmental Health Sciences Research Triangle Park, NC 27709, USA

1To Whom reprint request should be addressed

A simple and unique procedure for the isolation of intact basement membrane from Syrian hamster lung was developed. The method involved an initial 24 h extraction of minced lungs with 0.3 M acetic acid followed by treatment with N-lauroyl sarcosine, an anionic detergent. The tissue was washed several times in 0.85% NaCl and subjected to deoxyribonuclease treatment followed by washings with 0.85% NaCl and distilled water. The residue was shown to be basement membrane by electron microscopy and by amino acid analysis. The basement membrane was radiolabelled by reductive alkylation and had a specific activity of 3–5 x 105 c.p.m./mg and 80–90% of the radiolabel was present in the glycoprotein component of the basement membrane. The abilities of malignant fibrosarcoma cell lines to degrade the [3H]basement membrane was examined. A simple assay to measure degradation of [3H]basement membrane was developed based on the solubilization of the insoluble material after degradation. When added to growing tumor cells in the presence of growth medium and serum, the [3H]basement membrane was solubilized extensively. The reaction was linear for 24 h at which time up to 90% of the labelled material had been released. In contrast, <5% of the label was solubilized in medium plus serum alone or in the presence of normal Syrian hamster embryo cells. A preneoplastic cell line was also capable of degrading the [3H]basement membrane. The solubilization of the [3H]basement membrane was primarily due to degradation of the glycoproteins of the basement membrane as shown by Sephadex G-200 gel chromatography. The abilities of the tumor cells to degrade the [3H]basement membrane correlated with their fibrinolytic activity and inhibitors of plasmin inhibited the reaction. Furthermore, the activity of the cells in this assay was dependent upon the presence of plasminogen in the medium. No degradation of [3H]basement membrane was observed if plasminogen depleted serum was employed, but complete degradation was accomplished if purified plasminogen was added to the medium with plasminogen-depleted serum. These results indicate a role for plasminogen activator in the pathogenesis of invasive tumor cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. H. Mahabeleshwar and G. C. Kundu
Syk, a Protein-tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor kappa B-mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3'-Kinase Activity in Breast Cancer Cells
J. Biol. Chem., February 14, 2003; 278(8): 6209 - 6221.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Sliva, M. T. Rizzo, and D. English
Phosphatidylinositol 3-Kinase and NF-kappa B Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator
J. Biol. Chem., January 25, 2002; 277(5): 3150 - 3157.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. E. Dunn, J. V. Torres, J. S. Oh, D. M. Cykert, and J. C. Barrett
Up-Regulation of Urokinase-Type Plasminogen Activator by Insulin-like Growth Factor-I Depends upon Phosphatidylinositol-3 Kinase and Mitogen-activated Protein Kinase Kinase
Cancer Res., February 1, 2001; 61(4): 1367 - 1374.
[Abstract] [Full Text]


Home page
DevelopmentHome page
P. McGuire and S. Alexander
Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro
Development, January 7, 1993; 118(3): 931 - 939.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.